Inactief instrument

Koers Cadence Pharmaceuticals, Inc.

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Actavis : Factbox - M&A frenzy transforming global pharma	06-05-14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results	28-02-14
Cadence Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.	12-02-14
Cadence Pharmaceuticals, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders	11-02-14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance	13-01-14

Managers	Titel	Leeftijd	Van
Bryan Reasons PSD	President	56	-
Diane K. Sheehan HRO	Human Resources Officer	54	01-05-06

Besturend	Titel	Leeftijd	Van
Bryan Reasons PSD	President	56	-
Marvin R. Haselhorst BRD	Director/Board Member	-	19-03-14

Sector

	Vaira. 1 jan.	Kapi.
CSL LIMITED	-4,66%	86,13 mld.
SAMSUNG BIOLOGICS CO.,LTD.	+1,32%	39,82 mld.
BIOGEN INC.	-19,27%	30,42 mld.
UCB	+57,86%	25,23 mld.
BIOMARIN PHARMACEUTICAL INC.	-16,09%	15,35 mld.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14%	11,95 mld.
INCYTE CORPORATION	-17,69%	11,6 mld.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00%	11,51 mld.
SWEDISH ORPHAN BIOVITRUM AB	+5,24%	8,71 mld.